ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,348Medicare Part D Prescriptions Filled, Including Refills

Rank: 319 out of 1456

$867K Total Retail Price of All Prescriptions

Rank: 159 out of 1456

525 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

6% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 10,276 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 458 411 1 2
SYNTHROID 409 402 2 37
ATORVASTATIN CALCIUM 397 376 3 11
LEVOTHYROXINE SODIUM 383 356 4 4
AMLODIPINE BESYLATE 317 299 5 1
METFORMIN HCL ER 257 235 6 54
FUROSEMIDE 254 225 7 7
CRESTOR 240 217 8 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 233 217 9 24
OMEPRAZOLE 229 212 10 5
LISINOPRIL 191 183 11 3
HYDROCHLOROTHIAZIDE 185 173 12 10
METFORMIN HCL 177 155 13 8
SPIRONOLACTONE 166 163 14 73
BYSTOLIC 156 156 15 102
ZOLPIDEM TARTRATE 142 128 16 14
ALLOPURINOL 135 135 17 31
CYMBALTA 129 112 18 52
LANTUS SOLOSTAR 122 91 19 120
BENICAR HCT 118 118 20 160
LOSARTAN POTASSIUM 109 109 21 16
NEXIUM 106 87 22 23
ATENOLOL 96 84 23 18
LANTUS 96 75 23 50
LOSARTAN-HYDROCHLOROTHIAZIDE 96 79 23 41
CELEBREX 94 93 26 88
CARVEDILOL 93 93 27 20
LIPITOR 85 76 28 76
ONGLYZA 85 63 28 202
HYDROCODONE-ACETAMINOPHEN 85 55 S3 28 6
RAMIPRIL 84 84 31 98
AMITRIPTYLINE HCL 76 64 R 32 70
POLYETHYLENE GLYCOL 3350 76 65 32 85
PRAVASTATIN SODIUM 75 73 34 9
METOPROLOL SUCCINATE 74 71 35 19
SPIRIVA 74 64 35 75
PRISTIQ ER 73 58 37 342
PEN NEEDLE 73 56 37 131
TAMSULOSIN HCL 70 65 39 34
ALPRAZOLAM 70 68 39 149
TRIAMTERENE-HCTZ 68 64 41 49
TRAMADOL HCL 66 50 42 17
BYDUREON 65 54 43 460
EXELON 65 65 43 105
DIOVAN 64 64 45 35
BENICAR 63 63 46 130
TRIAMTERENE-HYDROCHLOROTHIAZID 61 51 47 201
ADVAIR DISKUS 61 52 47 63
POTASSIUM CHLORIDE 59 59 49 15
PROAIR HFA 59 43 49 69
RANITIDINE HCL 59 48 49 27
DEXILANT 58 48 52 169
KLOR-CON 8 56 55 53 255
GLIMEPIRIDE 55 55 54 33
ALENDRONATE SODIUM 54 54 55 36
FLUTICASONE PROPIONATE 53 37 56 28
FLUOXETINE HCL 52 32 57 55
JANUVIA 50 42 58 68
COUMADIN 50 50 58 225
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.